Full text is available at the source.
Abstract
A study assessed the knowledge, attitudes, and practices of GLP-1 receptor agonist users in Saudi Arabia.
- There is a rapid increase in the use of GLP-1 receptor agonists for weight management and blood sugar control in Saudi Arabia.
- Concerns exist regarding the inappropriate use and safety of GLP-1 receptor agonists among users.
- Misconceptions about GLP-1 receptor agonist therapies are prevalent among the user population.
- Factors associated with knowledge, attitudes, and practices of users were identified in the assessment.
Simplified